AmirKhandaniMD

Nuclear Medicine • Chapel Hill, NC

Professor, Radiology, University of North Carolina at Chapel Hill School of Medicine

Join to view full profile

Dr. Khandani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Khandani's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27599
Phone+1 919-966-1234

Fax+1 919-843-5515
Is this information wrong?

Education & Training

Medizinische Fakultät Universität zu KölnClass of 1992

Certifications & Licensure

NC State Medical License 2003 - 2024
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer Start of enrollment: 2005 Jul 01
Completed
Not Applicable
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
Completed
Phase 1
PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study Start of enrollment: 2012 Oct 01
Completed
Hybrid PET/MR in the Therapy of Cervical Cancer Start of enrollment: 2012 Oct 01
Completed
Join now to see all

Publications & Presentations

PubMed

PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers.
Rathmell, W., Nimmagadda, S., Rowe, S., Oldan, J., Schroeder, J., Hoffman-Censits, J., Milowsky, M., Solnes, L., Gorin, M., Khandani, A.> ;PET Clinics. 2024 Apr 1
One institutions' experience with a true standard 15 mCi dose of I-131 for the treatment of Graves' disease.
Mitchel A Muhleman, Ali Fahim, Thad Benefield, Jorge D Oldan, Amir H Khandani> ;Nuclear Medicine Communications. 2023 Jan 1
1 citations
Rubidium Uptake in Chest Tumors on PET/CT.
Jorge D Oldan, Abiola D Femi-Abodunde, Mitchel A Muhleman, Amir H Khandani> ;World Journal of Nuclear Medicine. 2022 Mar 1
Incidental renal masses on SPECT/CT and PET/CT.
Jorge D Oldan, Amir H Khandani> ;American Journal of Nuclear Medicine and Molecular Imaging. 2022 Jan 1
Incidental findings on a Tc99m-SESTAMIBI parathyroid scan post COVID-19 vaccination.
Mitchel A Muhleman, Jorge D Oldan, Amir H Khandani> ;American Journal of Nuclear Medicine and Molecular Imaging. 2022 Jan 1
25 citations
Pretherapy metabolic tumor volume associates with response to CD30 CAR T cells in Hodgkin lymphoma.
Timothy J Voorhees, Beibo Zhao, Jorge Oldan, George E Hucks, Amir H. Khandani, Christopher Dittus, Jennifer S. Smith, J. Kaitlin Morrison, Catherine Cheng, Anastasia I...> ;Blood Advances. 2021 Oct 19
7 citations
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
Stephanie I. Kim, Andy H. Szeto, Katherine P. Morgan, Blaine Brower, Mary W. Dunn, Amir H. Khandani, Paul A. Godley, Tracy L. Rose, Ethan Basch, Matthew I. Milowsky, Y...> ;Plos One. 2021 Jun 21
3 citations
Patterns of Recurrence, Detection Rates, and Impact of 18-F Fluciclovine PET/CT on the Management of Men With Recurrent Prostate Cancer.
Jamie Michael, Amir H. Khandani, Ramsankar Basak, Hung-Jui Tan, Trevor J. Royce, Eric Wallen, Young E. Whang, Tracy L. Rose, Matthew I. Milowsky, Marc A. Bjurlin> ;Urology. 2021 Jan 29
1 citations
Salvage Pelvic Lymph Node Dissection and Current State of Imaging for Recurrent Prostate Cancer: Does a Standard Exist?
Hannah McCloskey, Jesse Jacobs, Ibardo Zambrano, Theodore Moore, Amir H. Khandani, Marc A. Bjurlin> ;Current Urology Reports. 2020 Nov 7
1 citations
Detectable size of melanoma metastases to brain on PET/CT.
Jorge Oldan, Samuel Glaubiger, Amir H. Khandani, Valerie Jewells> ;Annals of Nuclear Medicine. 2020 May 25
Outcome of radioiodine therapy in thyroid cancer patients with recent contrasted computed tomography.
Justin D Rodriguez, Deepa Kirk, Thad Benefield, Susan J. Maygarden, Karla Pou, Lawrence T. Kim, Trevor Hackman, Amir H. Khandani> ;Nuclear Medicine Communications. 2020 Mar 1
3 citations
Visual and semiquantitative analysis of 82Rb uptake in malignant tumors on PET/CT: first systematic analysis
Amir H. Khandani, Clayton W. Commander, Hemant Desai, Jorge Oldan, Terence Z. Wong, Thad Benefield, Marijana Ivanovic> ;Nuclear Medicine Communications. 2019 May 1
4 citations
Trapping of 18F-Fluciclovine (FACBC) in Superior Sagittal Sinus.
Jorge Oldan, Seth M Miller, Andrew Barnes, Amir H. Khandani> ;Clinical Nuclear Medicine. 2019 Jan 1
1 citations
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
Jorge Oldan, Amir H. Khandani, Julia R. Fielding, Ellen L. Jones, Paola A. Gehrig, Tiffany Sills, Pinakpani Roy, Weili Lin> ;World Journal of Nuclear Medicine. 2018 Oct 1
22 citations
Subsequent experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy
Jorge Oldan, Hae Won Shin, Amir H. Khandani, Carlos A. Zamora, Thad Benefield, Valerie Jewells> ;Seizure. 2018 Oct 1
26 citations
Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma
Qingbo Yin, Sheng-Che Hung, W.K. Rathmell, L. Shen, Li Wang, Weili Lin, Julia R. Fielding, Amir H. Khandani, Michael Woods, Mathew I. Milowsky, Samira A. Brooks, Eric ...> ;Clinical Radiology. 2018 Sep 1
Frequency of high blood glucose prior to FDG PET.
Amir H. Khandani, Isabel M. Bravo, Parth S. Patel, Marijana Ivanovic, Deepa Kirk> ;Abdominal Radiology. 2017 May 1
47 citations
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof...
Qingbo Yin, Sheng-Che Hung, Li Wang, Weili Lin, Julia R. Fielding, W. Kimryn Rathmell, Amir H. Khandani, Michael Woods, Matthew I. Milowsky, Samira A. Brooks, Eric Wal...> ;Scientific Reports. 2017 Mar 3
56 citations
Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study.
Timothy M. Zagar, Orit Kaidar-Person, Xiaoli Tang, Ellen E. Jones, J Matney, Shiva K. Das, Rebecca L. Green, Arif Sheikh, Amir H. Khandani, William H. McCartney, Jorge...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Apr 1
18 citations
Alternate metabolic programs define regional variation of relevant biological features in renal cell carcinoma progression.
Samira A. Brooks, Amir H. Khandani, Julia R. Fielding, Weili Lin, Tiffany Sills, Yueh Z. Lee, Alexandra Arreola, Matthew I. Milowsky, Eric Wallen, Michael Woods, Angie...> ;Clinical Cancer Research. 2016 Jun 15
Comparative effectiveness of follow-up imaging approaches in pancreatic cancer.
Katherine E. Reeder-Hayes, Janet K. Freburger, John Feaganes, Sharon Peacock Hinton, Louise M. Henderson, Mark W. Massing, Anna P. Schenck, Sally C. Stearns, William R...> ;Journal of Comparative Effectiveness Research. 2014 Oct 28
8 citations
PET/CT with (124)I-cG250: great potential and some open questions.
Amir H. Khandani, W.K. Rathmell, Eric Wallen, Marija Ivanovic> ;AJR. American Journal of Roentgenology. 2014 Jul 23
20 citations
Positron emission tomography and stage migration in head and neck cancer.
Noam A. VanderWalde, Ramzi G. Salloum, Tsai-Ling Liu, Mark C. Hornbrook, Maureen C. O'Keeffe Rosetti, Debra P. Ritzwoller, Paul A. Fishman, Jennifer Elston Lafata, Ami...> ;JAMA Otolaryngology-- Head & Neck Surgery. 2014 Jul 1
7 citations
Is Image Registration of Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography for Head-and-Neck Cancer Treatment Planning Necessary?
David V. Fried, Michael S. Lawrence, Amir H. Khandani, Julian G. Rosenman, Tim J. Cullip, Bhishamjit S. Chera> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Nov 1
62 citations
Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non–Small-Cell Lung Cancer: Results of a Phase I/II Trial
Mark A. Socinski, Thomas E. Stinchcombe, Dominic T. Moore, Scott N. Gettinger, Roy H. Decker, W. Jeffrey Petty, A. William Blackstock, Garry Schwartz, Scott P. Lankfor...> ;Journal of Clinical Oncology. 2012 Oct 8
Join now to see all

Press Mentions

Theranostics with RAI Offer a Precision Approach to Treating Differentiated Thyroid CancerJuly 29th, 2019